PARLIAMENTARY EARLY DAY MOTION
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE AND ALZHEIMER'S DISEASE (17 July 2005)

That this House congratulates the Department of Health on negotiating a reduction in the cost of branded drugs to the NHS of £112 million in the first five months of 2005; believes that these savings should be made available for other treatments; notes the recent draft guidance from the National Institute for Health and Clinical Excellence (NICE) which, if upheld, would deny effective treatments to thousands of people with Alzheimer's disease, undermining the historic inclusiveness of the NHS for all patients; and calls on the Secretary of State for Health carefully to consider the representations made by patient groups to the current NICE Social Values Consultation, and to ensure a further draft is circulated for consultation before final decisions are made which might disadvantage certain patient groups.

Sponsored by:
Roger Berry (Labour)